Trade Summary

Yesterday, Raykov Rosty, serving as Former Director at FENNEC PHARMACEUTICALS INC. (FENC), sold 10,000 shares at $9.58 per share, for a total transaction value of $95,800.00. Following this transaction, Raykov Rosty now holds 131,633 shares of FENC.

This sale represents a 7.06% decrease in Raykov Rosty's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, August 3, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, August 4, 2026 at 4:05 PM ET, 1 day after the trade was made.

FENNEC PHARMACEUTICALS INC. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.